Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michelle Bradbury
Sloan Kettering Inst Can Research, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Elucida Oncology, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached report.
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
PUBLIC HEALTH RELEVANCE Metastatic melanoma, one of the fastest rising cancers in the United States, and malignant brain tumors have a very poor prognosis, and offer very few treatment options. We propose a multi-institutional, multi-disciplinary Center to advance, translate, and disseminate a suite of ultrasmall (<10 nm) multimodality (PET/optical) silica- organic hybrid nanoparticles with tunable size, brightness, and geometry. Further, as a result of their proven favorable pharmacokinetics, clearance profiles, and tumor-to-background ratios in human patients, these particle probes offer a more realistic solution to overcome existing limitations, and should dramatically impact cancer care.
Filed on July 10, 2017.
Tell us what you know about Michelle Bradbury's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michelle Bradbury filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Technologies, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Nanotechnologies LLC | $0 - $4,999 |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Elucida Oncology, Inc. | Value cannot be readily determined |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Nanotechnologies LLC | Value cannot be readily determined |
| Michelle Bradbury | Sloan Kettering Inst Can Research | Conflict of Interest | Claymore Technologies, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.